NL8203067A - Ergopeptinederivaten, werkwijzen voor hun bereiding, farmaceutische preparaten die ze bevatten en hun toepassing bij therapeutische behandeling. - Google Patents

Ergopeptinederivaten, werkwijzen voor hun bereiding, farmaceutische preparaten die ze bevatten en hun toepassing bij therapeutische behandeling. Download PDF

Info

Publication number
NL8203067A
NL8203067A NL8203067A NL8203067A NL8203067A NL 8203067 A NL8203067 A NL 8203067A NL 8203067 A NL8203067 A NL 8203067A NL 8203067 A NL8203067 A NL 8203067A NL 8203067 A NL8203067 A NL 8203067A
Authority
NL
Netherlands
Prior art keywords
acid addition
addition salt
formula
compounds
compound
Prior art date
Application number
NL8203067A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8203067A publication Critical patent/NL8203067A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL8203067A 1981-08-07 1982-08-02 Ergopeptinederivaten, werkwijzen voor hun bereiding, farmaceutische preparaten die ze bevatten en hun toepassing bij therapeutische behandeling. NL8203067A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH510481 1981-08-07
CH5104/81A CH649300A5 (de) 1981-08-07 1981-08-07 Ergopeptinderivate, ihre herstellung und verwendung.

Publications (1)

Publication Number Publication Date
NL8203067A true NL8203067A (nl) 1983-03-01

Family

ID=4287999

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8203067A NL8203067A (nl) 1981-08-07 1982-08-02 Ergopeptinederivaten, werkwijzen voor hun bereiding, farmaceutische preparaten die ze bevatten en hun toepassing bij therapeutische behandeling.

Country Status (27)

Country Link
US (3) US4542135A (enExample)
JP (1) JPS5843982A (enExample)
AT (1) AT382156B (enExample)
AU (1) AU558414B2 (enExample)
BE (1) BE894046A (enExample)
CA (1) CA1191802A (enExample)
CH (1) CH649300A5 (enExample)
CS (1) CS235303B2 (enExample)
DD (2) DD206379A5 (enExample)
DE (1) DE3228230A1 (enExample)
DK (1) DK352082A (enExample)
ES (2) ES514766A0 (enExample)
FI (1) FI72979C (enExample)
FR (1) FR2511003B1 (enExample)
GB (1) GB2109795B (enExample)
GR (1) GR77262B (enExample)
HU (2) HU190405B (enExample)
IE (1) IE53647B1 (enExample)
IL (1) IL66471A (enExample)
IT (1) IT1152489B (enExample)
MY (1) MY8600311A (enExample)
NL (1) NL8203067A (enExample)
NZ (1) NZ201504A (enExample)
PH (1) PH22998A (enExample)
PT (1) PT75384B (enExample)
SE (1) SE452011B (enExample)
ZA (1) ZA825727B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
JPS60104129A (ja) * 1983-11-11 1985-06-08 Hitachi Ltd フッ素含有ポリアミド酸誘導体及びポリイミドの製造方法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
PT628042E (pt) * 1992-12-24 2002-01-30 Pharmacia & Upjohn Spa Derivados de ergolina serotoninergicos
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US20070022720A1 (en) * 2005-07-27 2007-02-01 The Toro Company Cleaner for cooling system screen of outdoor power equipment unit
SG181896A1 (en) * 2009-12-23 2012-07-30 Map Pharmaceuticals Inc Novel ergoline analogs
KR20140042868A (ko) 2011-06-23 2014-04-07 맵 파마슈티컬스, 인코포레이티드 신규한 플루오로에르골린 유사체
EP2793580A4 (en) 2011-12-19 2015-05-20 Map Pharmaceuticals Inc NEW DERIVATIVES OF ISO-ERGOLINE
AU2012355983A1 (en) 2011-12-21 2015-01-22 Map Pharmaceuticals, Inc. Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CZ2013590A3 (cs) * 2013-07-25 2014-09-03 Teva Czech Industries S.R.O. Izolovaný kmen houby Claviceps purpurea (Fr.) Tul., CCM 8404
CN113308442B (zh) * 2021-04-28 2023-06-27 天津大学 重组酿酒酵母菌株及其构建方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314959A (en) * 1961-05-10 1967-04-18 Sandoz Ltd Intermediates for the synthesis of ergot alkaloids
FR2292M (fr) * 1962-06-27 1964-01-27 Sandoz Sa Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
CH602766A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag 10-Alpha-methoxy-di:hydro-beta-ergosine derivs.
CH602765A5 (enExample) * 1974-09-27 1978-07-31 Sandoz Ag
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
CH626373A5 (enExample) * 1977-02-22 1981-11-13 Sandoz Ag
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
DE2717953A1 (de) * 1977-04-22 1978-10-26 Sandoz Ag Neue therapeutische mischung und verfahren zu deren herstellung
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
CH636011A5 (en) * 1978-01-01 1983-05-13 Sandoz Ag Administration forms for organic compounds
EP0003286B1 (de) * 1978-01-20 1982-03-24 Sandoz Ag Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2803543A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Ergopeptidalkaloidderivate, ihre verwendung und herstellung
YU40046B (en) * 1978-09-04 1985-06-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-9,10-dihydroergosine
US4609731A (en) * 1979-10-10 1986-09-02 Sandoz Ltd. Process for brominating ergot alkaloids
DD200571A1 (de) * 1981-07-22 1983-05-18 Alfred Baumert Verfahren zur herstellung von ergopeptinen mit modifiziertem prolinteil
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
PT75384A (en) 1982-09-01
GR77262B (enExample) 1984-09-11
US4681880A (en) 1987-07-21
PH22998A (en) 1989-02-24
GB2109795A (en) 1983-06-08
ES8402348A1 (es) 1984-01-16
SE452011B (sv) 1987-11-09
ES526119A0 (es) 1985-04-16
JPH0437836B2 (enExample) 1992-06-22
FI822670A0 (fi) 1982-07-30
FR2511003B1 (fr) 1986-12-05
US4542135A (en) 1985-09-17
FI822670L (fi) 1983-02-08
IL66471A (en) 1986-02-28
CA1191802A (en) 1985-08-13
AU8678582A (en) 1983-03-03
NZ201504A (en) 1986-08-08
JPS5843982A (ja) 1983-03-14
IT1152489B (it) 1986-12-31
CS235303B2 (en) 1985-05-15
ATA302682A (de) 1986-06-15
MY8600311A (en) 1986-12-31
IE821906L (en) 1983-02-07
US4804660A (en) 1989-02-14
FI72979C (fi) 1987-08-10
AT382156B (de) 1987-01-26
FR2511003A1 (fr) 1983-02-11
IT8222768A1 (it) 1984-02-06
PT75384B (en) 1985-06-28
FI72979B (fi) 1987-04-30
BE894046A (fr) 1983-02-07
SE8204585L (sv) 1983-02-08
HUT37960A (en) 1986-03-28
IL66471A0 (en) 1982-12-31
DE3228230A1 (de) 1983-02-17
ES514766A0 (es) 1984-01-16
DD211582A5 (de) 1984-07-18
CH649300A5 (de) 1985-05-15
AU558414B2 (en) 1987-01-29
DD206379A5 (de) 1984-01-25
DK352082A (da) 1983-02-08
ES8504825A1 (es) 1985-04-16
ZA825727B (en) 1984-03-28
IT8222768A0 (it) 1982-08-06
HU190405B (en) 1986-09-29
SE8204585D0 (sv) 1982-08-05
HU193373B (en) 1987-09-28
GB2109795B (en) 1985-07-03
IE53647B1 (en) 1989-01-04

Similar Documents

Publication Publication Date Title
US4542135A (en) 9'Thia-ergots
CA2135751C (en) 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
US20020143021A1 (en) Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
NZ511015A (en) 1, 6-Dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives useful for treating impotence
SK498A3 (en) Macrolides, a method for their preparation and a pharmaceutical composition containing the same
EP2066679B1 (en) Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
CN109563097B (zh) 一种7H-吡咯并[2,3-d]嘧啶类化合物的晶型、盐型及其制备方法
Al Subeh et al. Three diketomorpholines from a Penicillium sp.(strain G1071)
FI59254B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergopeptinderivat
JP2992769B2 (ja) １，２―ジヒドロ―３ｈ―ジベンズイソキノリン―１，３―ジオン抗ガン剤
US6878737B2 (en) Reversal of multidrug resistance in human colon carcinoma cells
NL8004000A (nl) Werkwijze voor de bereiding van een geneesmiddel op basis van ergolinederivaten en de bereiding van de actieve stof.
HU205932B (en) Process for producing triacetate derivative of bu-3420t antibioticum and pharmaceutical compositions containing them
SU1056901A3 (ru) Способ получени сесквитерпеновых производных или их солей
Saour et al. Synthesis of new levofloxacin derivatives and their biological activity
Nandeshwarappa et al. Nitrogen and selenium containing heterocycles: Part-2: Synthesis and antimicrobial activities of novel S-5-(2-oxo-2H-selenopyrano [2, 3-b] quinolin-3-yl)-1, 3, 4-oxadiazol-2-yl-2-cyanoethanethioates
US4895854A (en) Antitumor alkaloids
US6583171B1 (en) Antineoplastic agents
Minghetti et al. The history of ergot
US4004011A (en) 3-Pyridylamine substituted ergolines
AU759990B2 (en) Dithiolopyrrolones and their corresponding monoxides and dioxides as antineoplastic agents
JP2003503412A (ja) 海洋放線菌に由来する新規のインドロカルバゾールアルカロイド
JPH10182648A (ja) Ｔａｎ−２４７４関連化合物、その製造法および用途
WO2007089657A2 (en) Crystalline forms of a farnesyl dibenzodiazepinone
CN107056731B (zh) 一种苯并噻二嗪酮类衍生物，其制备方法和用途

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed